Zhenshun Cheng
Economics and Econometrics · 2020
A researcher in the Science corpus: 9 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Economics and Econometrics — 7 citations into it
- Statistics and Probability — 7 citations into it
Whom Zhenshun Cheng trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Zhenshun Cheng's perspective
Ordered by how strongly the researchers Zhenshun Cheng trusts endorse each paper. Same corpus, a different order for every researcher.
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (Preventive Medicine)
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations (British medical journal)
- Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. (New England Journal of Medicine)
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (Nature)
- Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam (New England Journal of Medicine)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
- A novel coronavirus associated with severe acute respiratory syndrome. (New England Journal of Medicine)
- [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi)
- Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys (Nature)
Their papers
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. (2020) — 21,906 citations
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial (2020) — 3,142 citations
- Cross-Sectional Studies: Strengths, Weaknesses, and Recommendations. (2020) — 1,919 citations
- The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients (2020) — 794 citations
- Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial (2020) — 714 citations
- Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study (2020) — 1,152 citations
- Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China (2020) — 881 citations
- [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (2020) — 28,829 citations
- A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) (2020) — 2,153 citations